Ainos Stock Price, News & Analysis (NASDAQ:AIMD) $0.60 +0.00 (+0.15%) (As of 05:11 PM ET) Add Compare Share Share Today's Range$0.60▼$0.6050-Day Range$0.58▼$0.6952-Week Range$0.50▼$1.83Volume66,413 shsAverage Volume349,087 shsMarket Capitalization$12.15 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsShort InterestSocial Media About AinosAinos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Read More AIMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AIMD Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive AIMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today11/28/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AIMD CUSIPN/A CIK1014763 Webwww.ainos.com Phone858-869-2986Fax806-376-9301Employees43Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,010,000.00 Net Margins-874.50% Pretax Margin-874.41% Return on Equity-31.92% Return on Assets-28.16% Debt Debt-to-Equity Ratio0.19 Current Ratio3.71 Quick Ratio3.45 Sales & Book Value Annual Sales$3.52 million Price / Sales3.45 Cash FlowN/A Price / Cash FlowN/A Book Value$1.73 per share Price / Book0.35Miscellaneous Outstanding Shares20,290,000Free Float19,370,000Market Cap$12.15 million OptionableNot Optionable Beta1.32 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Chun-Hsien Tsai (Age 53)Chairman of Board, President & CEO Comp: $116.96kMr. Lawrence Kennedy Lin (Age 54)Executive Vice President of Operations Comp: $133.02kMs. Meng-Lin SungChief Financial OfficerMr. John Junyong Lee Esq. (Age 56)Chief Legal Counsel, Corporate Counsel & Secretary Mr. Chih-Heng Lu (Age 43)Director of Corporate Developoment Key CompetitorsProMIS NeurosciencesNASDAQ:PMNCNS PharmaceuticalsNASDAQ:CNSPNeuroBo PharmaceuticalsNASDAQ:NRBOEvelo BiosciencesNASDAQ:EVLOTonix PharmaceuticalsNASDAQ:TNXPView All Competitors AIMD Stock Analysis - Frequently Asked Questions How have AIMD shares performed in 2023? Ainos' stock was trading at $0.66 at the beginning of the year. Since then, AIMD stock has decreased by 9.3% and is now trading at $0.5989. View the best growth stocks for 2023 here. Are investors shorting Ainos? Ainos saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 25,800 shares, a drop of 6.9% from the October 31st total of 27,700 shares. Based on an average daily trading volume, of 31,800 shares, the short-interest ratio is presently 0.8 days. Approximately 0.4% of the company's stock are short sold. View Ainos' Short Interest. When is Ainos' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024. View our AIMD earnings forecast. When did Ainos IPO? (AIMD) raised $3 million in an initial public offering on Tuesday, August 9th 2022. The company issued 800,000 shares at a price of $4.25 per share. Maxim Group served as the underwriter for the IPO and Brookline Capital Markets was co-manager. How do I buy shares of Ainos? Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:AIMD) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.